Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for NUVB

Stock Name	Nuvation Bio Inc
Ticker	NUVB(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US67080N1019

Show aggregate NUVB holdings

News associated with NUVB

Nuvation Bio (NYSE:NUVB) Earns “Outperform” Rating from Wedbush: Nuvation Bio (NYSE:NUVB – Get Free Report)‘s stock had its “outperform” rating reissued by equities researchers at Wedbush in a report released on Monday,Benzinga reports. They currently have a $6.00 price target on the stock. Wedbush’s price target indicates a potential upside of 79.10% from the stock’s current price. A number of other research firms […] - 2025-09-10 02:54:50
Nuvation Bio (NYSE:NUVB) Stock Rating Upgraded by Wall Street Zen: Nuvation Bio (NYSE:NUVB – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a note issued to investors on Sunday. Other equities analysts also recently issued research reports about the stock. Royal Bank Of Canada lifted their target price on shares of […] - 2025-08-19 02:46:54
Teacher Retirement System of Texas Sells 5,636 Shares of Nuvation Bio Inc. (NYSE:NUVB): Teacher Retirement System of Texas decreased its position in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 8.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 58,866 shares of the company’s stock after selling 5,636 shares during the quarter. Teacher Retirement […] - 2025-07-22 04:16:50
Nuvation Bio Inc. (NYSE:NUVB) Receives $7.17 Consensus Price Target from Brokerages: Shares of Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) have received an average rating of “Buy” from the five brokerages that are presently covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average […] - 2025-07-10 02:19:09
Wealth Enhancement Advisory Services LLC Takes Position in Nuvation Bio Inc. (NYSE:NUVB): Wealth Enhancement Advisory Services LLC acquired a new position in Nuvation Bio Inc. (NYSE:NUVB – Free Report) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 10,140 shares of the company’s stock, valued at approximately $27,000. A number of other hedge funds also recently added to or reduced their stakes in NUVB. BNP Paribas Financial […] - 2025-06-19 04:36:44
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 122,187 Shares of Nuvation Bio Inc. (NYSE:NUVB): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 54.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 347,806 shares of the company’s stock after purchasing an […] - 2025-06-11 04:36:52
Wellington Management Group LLP Grows Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB): Wellington Management Group LLP raised its position in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 8.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 676,024 shares of the company’s stock after buying an additional 52,051 shares during the period. Wellington Management Group LLP’s holdings in Nuvation Bio were worth $1,798,000 […] - 2025-06-06 05:04:54
Nuvation Bio (NYSE:NUVB) Earns Market Outperform Rating from JMP Securities: Nuvation Bio (NYSE:NUVB – Get Free Report)‘s stock had its “market outperform” rating restated by research analysts at JMP Securities in a report issued on Monday,Benzinga reports. They presently have a $6.00 target price on the stock. JMP Securities’ price target would suggest a potential upside of 144.40% from the company’s current price. NUVB has […] - 2025-06-04 02:50:56
Nuvation Bio Inc. (NYSE:NUVB) Shares Sold by Two Sigma Advisers LP: Two Sigma Advisers LP cut its stake in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 10.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 476,400 shares of the company’s stock after selling 57,500 shares during the period. Two Sigma Advisers […] - 2025-06-01 07:12:50
Nuveen Asset Management LLC Has $4.08 Million Holdings in Nuvation Bio Inc. (NYSE:NUVB): Nuveen Asset Management LLC lowered its stake in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 2.9% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,534,125 shares of the company’s stock after selling 46,270 shares during the quarter. Nuveen Asset Management LLC’s holdings in Nuvation Bio were worth $4,081,000 as of its […] - 2025-06-01 05:44:57
Biotech Stocks Facing FDA Decision In June 2025: (RTTNews) - As May draws to a close, it's time to turn our attention to the FDA's upcoming slate of decisions. From January through May 2025, the U.S. regulatory agency has approved 13 novel drugs, a modest decline from the 16 approvals recorded during the same period in 2024. - 2025-05-30 06:02:12
Nuvation Bio Inc. (NYSE:NUVB) Shares Sold by Dimensional Fund Advisors LP: Dimensional Fund Advisors LP trimmed its holdings in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 26.1% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,227,152 shares of the company’s stock after selling 432,720 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Nuvation Bio were worth $3,264,000 at the […] - 2025-05-14 04:44:52
Nuvation Bio Inc. (NYSE:NUVB) Shares Purchased by Price T Rowe Associates Inc. MD: Price T Rowe Associates Inc. MD boosted its holdings in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 4.5% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 225,025 shares of the company’s stock after buying an additional 9,758 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Nuvation Bio were […] - 2025-05-13 04:32:47
Hsbc Holdings PLC Buys 25,870 Shares of Nuvation Bio Inc. (NYSE:NUVB): Hsbc Holdings PLC boosted its position in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 22.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 143,223 shares of the company’s stock after buying an additional 25,870 shares during the quarter. Hsbc Holdings PLC’s […] - 2025-05-09 06:18:53
Nuvation Bio (NYSE:NUVB) Trading Down 8.2% on Insider Selling: Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) shares fell 8.2% during mid-day trading on Tuesday following insider selling activity. The company traded as low as $2.18 and last traded at $2.19. 1,169,900 shares changed hands during trading, a decline of 45% from the average session volume of 2,140,547 shares. The stock had previously closed […] - 2025-05-08 02:42:49
Invesco Ltd. Buys 7,344 Shares of Nuvation Bio Inc. (NYSE:NUVB): Invesco Ltd. grew its stake in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 2.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 330,388 shares of the company’s stock after buying an additional 7,344 shares during the period. Invesco Ltd.’s holdings in Nuvation Bio were worth $879,000 as of its […] - 2025-05-02 05:54:49
XTX Topco Ltd Has $28,000 Holdings in Nuvation Bio Inc. (NYSE:NUVB): XTX Topco Ltd decreased its position in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 92.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,585 shares of the company’s stock after selling 121,444 shares during the period. XTX Topco […] - 2025-05-02 04:37:18
Legal & General Group Plc Raises Holdings in Nuvation Bio Inc. (NYSE:NUVB): Legal & General Group Plc lifted its stake in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 38.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 224,827 shares of the company’s stock after purchasing an additional 62,877 shares during the quarter. Legal & General […] - 2025-04-29 05:24:52
Renaissance Technologies LLC Sells 462,200 Shares of Nuvation Bio Inc. (NYSE:NUVB): Renaissance Technologies LLC reduced its position in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 44.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 566,800 shares of the company’s stock after selling 462,200 shares during the quarter. Renaissance Technologies LLC’s […] - 2025-04-29 04:44:59
Brokerages Set Nuvation Bio Inc. (NYSE:NUVB) PT at $7.83: Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) has been given an average rating of “Buy” by the six research firms that are presently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year […] - 2025-04-28 03:08:51
ExodusPoint Capital Management LP Has $206,000 Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB): ExodusPoint Capital Management LP reduced its position in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 6.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,280 shares of the company’s stock after selling 5,167 shares […] - 2025-04-14 04:46:55
KLP Kapitalforvaltning AS Makes New Investment in Nuvation Bio Inc. (NYSE:NUVB): KLP Kapitalforvaltning AS bought a new stake in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund bought 43,500 shares of the company’s stock, valued at approximately $116,000. A number of other hedge funds have also recently made changes to their positions in NUVB. Abacus Planning […] - 2025-04-10 04:20:48
Connor Clark & Lunn Investment Management Ltd. Buys 25,524 Shares of Nuvation Bio Inc. (NYSE:NUVB): Connor Clark & Lunn Investment Management Ltd. increased its holdings in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 6.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 422,260 shares of the company’s stock after buying an additional 25,524 shares during […] - 2025-03-21 06:59:10
Nuvation Bio Sees Unusually High Options Volume (NYSE:NUVB): Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) saw some unusual options trading on Thursday. Stock investors acquired 7,110 put options on the company. This represents an increase of approximately 7,800% compared to the typical daily volume of 90 put options. Wall Street Analysts Forecast Growth NUVB has been the subject of a number of […] - 2025-03-21 04:36:49
HC Wainwright Lowers Nuvation Bio (NYSE:NUVB) Price Target to $10.00: Nuvation Bio (NYSE:NUVB – Free Report) had its target price trimmed by HC Wainwright from $11.00 to $10.00 in a research report sent to investors on Monday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Other analysts have also issued reports about the stock. Royal Bank of Canada reissued an “outperform” […] - 2025-03-11 04:58:44

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc NUVB holdings

Date	Number of NUVB Shares Held	Base Market Value of NUVB Shares	Local Market Value of NUVB Shares	Change in NUVB Shares Held	Change in NUVB Base Value	Current Price per NUVB Share Held	Previous Price per NUVB Share Held
2025-09-30 (Tuesday)	137,933	USD 510,352	USD 510,352
2025-09-29 (Monday)	137,043	USD 441,278	USD 441,278
2025-09-26 (Friday)	137,043	USD 438,538	USD 438,538
2025-09-25 (Thursday)	137,043	USD 412,499	USD 412,499	0	USD -31,520	USD 3.01	USD 3.24
2025-09-24 (Wednesday)	137,043	USD 444,019	USD 444,019
2025-09-17 (Wednesday)	136,153	USD 443,859	USD 443,859	0	USD -1,361	USD 3.26	USD 3.27
2025-09-16 (Tuesday)	136,153	USD 445,220	USD 445,220

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NUVB by Blackrock for IE00B3VWM098

Show aggregate share trades of NUVB

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-11 BUY 1,776 3.350* 2.24
2025-08-21 SELL -444 2.740* 2.24 Profit of 994 on sale
2025-07-31 BUY 1,332 2.360* 2.24
2025-06-30 SELL -888 1.950* 2.24 Profit of 1,985 on sale
2025-06-25 SELL -444 1.880* 2.24 Profit of 995 on sale
2025-06-20 SELL -888 1.970* 2.25 Profit of 1,995 on sale
2025-05-23 BUY 444 2.300* 2.26
2025-05-19 SELL -444 2.300* 2.26 Profit of 1,004 on sale
2025-05-15 SELL -1,332 2.240* 2.26 Profit of 3,011 on sale
2025-05-12 SELL -444 2.150* 2.26 Profit of 1,005 on sale
2025-05-09 SELL -444 2.090* 2.26 Profit of 1,005 on sale
2025-04-30 SELL -444 2.250* 2.27 Profit of 1,007 on sale
2025-04-24 SELL -888 2.130* 2.27 Profit of 2,017 on sale
2025-04-17 SELL -444 1.970* 2.29 Profit of 1,015 on sale
2025-04-15 SELL -1,332 2.020* 2.29 Profit of 3,054 on sale
2025-04-14 SELL -1,335 2.020* 2.30 Profit of 3,065 on sale
2025-04-09 SELL -1,780 1.790* 2.31 Profit of 4,114 on sale
2025-04-07 SELL -3,115 1.800* 2.33 Profit of 7,242 on sale
2025-04-04 SELL -4,450 1.660* 2.33 Profit of 10,381 on sale
2025-03-31 BUY 445 1.760* 2.35
2025-03-19 SELL -890 1.980* 2.40 Profit of 2,137 on sale
2025-03-14 SELL -2,682 2.140* 2.42 Profit of 6,478 on sale
2025-03-13 SELL -896 2.210* 2.42 Profit of 2,167 on sale
2025-03-12 SELL -15,232 2.240* 2.42 Profit of 36,877 on sale
2025-03-07 SELL -896 2.020* 2.44 Profit of 2,184 on sale
2025-03-06 SELL -1,344 1.890* 2.45 Profit of 3,287 on sale
2025-03-03 SELL -448 1.820* 2.48 Profit of 1,109 on sale
2025-02-28 SELL -2,688 1.970* 2.48 Profit of 6,675 on sale
2025-02-26 SELL -448 1.980* 2.50 Profit of 1,120 on sale
2025-02-25 SELL -1,347 2.050* 2.51 Profit of 3,379 on sale
2025-02-18 BUY 2,240 2.320* 2.53
2025-02-13 BUY 448 2.290* 2.55
2025-02-12 BUY 448 2.280* 2.56
2025-02-11 BUY 1,344 2.230* 2.56
2025-02-06 BUY 4,032 2.410* 2.58
2025-01-27 BUY 448 2.500* 2.61
2024-12-30 BUY 2,235 2.620* 2.61
2024-12-06 BUY 1,788 2.850* 2.59
2024-12-05 BUY 447 2.770* 2.59
2024-12-04 BUY 2,235 2.750* 2.58
2024-11-29 BUY 2,235 2.900* 2.54
2024-11-27 BUY 1,788 2.890* 2.51
2024-11-26 SELL -33,975 2.890* 2.49 Profit of 84,737 on sale
2024-11-25 SELL -136,596 2.890* 2.48 Profit of 338,108 on sale
2024-11-21 BUY 4,830 2.700* 2.45
2024-11-20 BUY 2,898 2.580* 2.44
2024-11-18 BUY 11,582 2.560* 2.42
2024-11-12 BUY 7,712 2.930* 2.39
2024-11-08 BUY 4,820 2.880* 2.35
2024-11-07 BUY 14,430 2.620* 2.33
2024-11-06 BUY 1,924 2.540* 2.31
2024-10-31 BUY 962 2.210* 2.33
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-11	BUY	1,776	3.350*	2.24
2025-08-21	SELL	-444	2.740*	2.24 Profit of 994 on sale
2025-07-31	BUY	1,332	2.360*	2.24
2025-06-30	SELL	-888	1.950*	2.24 Profit of 1,985 on sale
2025-06-25	SELL	-444	1.880*	2.24 Profit of 995 on sale
2025-06-20	SELL	-888	1.970*	2.25 Profit of 1,995 on sale
2025-05-23	BUY	444	2.300*	2.26
2025-05-19	SELL	-444	2.300*	2.26 Profit of 1,004 on sale
2025-05-15	SELL	-1,332	2.240*	2.26 Profit of 3,011 on sale
2025-05-12	SELL	-444	2.150*	2.26 Profit of 1,005 on sale
2025-05-09	SELL	-444	2.090*	2.26 Profit of 1,005 on sale
2025-04-30	SELL	-444	2.250*	2.27 Profit of 1,007 on sale
2025-04-24	SELL	-888	2.130*	2.27 Profit of 2,017 on sale
2025-04-17	SELL	-444	1.970*	2.29 Profit of 1,015 on sale
2025-04-15	SELL	-1,332	2.020*	2.29 Profit of 3,054 on sale
2025-04-14	SELL	-1,335	2.020*	2.30 Profit of 3,065 on sale
2025-04-09	SELL	-1,780	1.790*	2.31 Profit of 4,114 on sale
2025-04-07	SELL	-3,115	1.800*	2.33 Profit of 7,242 on sale
2025-04-04	SELL	-4,450	1.660*	2.33 Profit of 10,381 on sale
2025-03-31	BUY	445	1.760*	2.35
2025-03-19	SELL	-890	1.980*	2.40 Profit of 2,137 on sale
2025-03-14	SELL	-2,682	2.140*	2.42 Profit of 6,478 on sale
2025-03-13	SELL	-896	2.210*	2.42 Profit of 2,167 on sale
2025-03-12	SELL	-15,232	2.240*	2.42 Profit of 36,877 on sale
2025-03-07	SELL	-896	2.020*	2.44 Profit of 2,184 on sale
2025-03-06	SELL	-1,344	1.890*	2.45 Profit of 3,287 on sale
2025-03-03	SELL	-448	1.820*	2.48 Profit of 1,109 on sale
2025-02-28	SELL	-2,688	1.970*	2.48 Profit of 6,675 on sale
2025-02-26	SELL	-448	1.980*	2.50 Profit of 1,120 on sale
2025-02-25	SELL	-1,347	2.050*	2.51 Profit of 3,379 on sale
2025-02-18	BUY	2,240	2.320*	2.53
2025-02-13	BUY	448	2.290*	2.55
2025-02-12	BUY	448	2.280*	2.56
2025-02-11	BUY	1,344	2.230*	2.56
2025-02-06	BUY	4,032	2.410*	2.58
2025-01-27	BUY	448	2.500*	2.61
2024-12-30	BUY	2,235	2.620*	2.61
2024-12-06	BUY	1,788	2.850*	2.59
2024-12-05	BUY	447	2.770*	2.59
2024-12-04	BUY	2,235	2.750*	2.58
2024-11-29	BUY	2,235	2.900*	2.54
2024-11-27	BUY	1,788	2.890*	2.51
2024-11-26	SELL	-33,975	2.890*	2.49 Profit of 84,737 on sale
2024-11-25	SELL	-136,596	2.890*	2.48 Profit of 338,108 on sale
2024-11-21	BUY	4,830	2.700*	2.45
2024-11-20	BUY	2,898	2.580*	2.44
2024-11-18	BUY	11,582	2.560*	2.42
2024-11-12	BUY	7,712	2.930*	2.39
2024-11-08	BUY	4,820	2.880*	2.35
2024-11-07	BUY	14,430	2.620*	2.33
2024-11-06	BUY	1,924	2.540*	2.31
2024-10-31	BUY	962	2.210*	2.33

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NUVB

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	1,074,355	0	2,292,105	46.9%
2025-09-18	1,820,481	397	3,632,174	50.1%
2025-09-17	611,236	680	2,394,879	25.5%
2025-09-16	1,065,371	6,900	3,187,078	33.4%
2025-09-15	1,328,746	819	3,182,948	41.7%
2025-09-12	1,825,382	300	3,959,369	46.1%
2025-09-11	964,222	32,598	2,836,764	34.0%
2025-09-10	580,621	0	1,959,229	29.6%
2025-09-09	996,992	143,246	2,655,113	37.5%
2025-09-08	2,494,675	318,478	7,032,551	35.5%
2025-09-05	3,960,825	30,655	9,825,419	40.3%
2025-09-04	1,779,407	37,716	4,486,193	39.7%
2025-09-03	811,928	0	2,727,927	29.8%
2025-09-02	517,285	0	1,335,394	38.7%
2025-08-29	345,543	0	999,985	34.6%
2025-08-28	635,194	7,200	2,279,506	27.9%
2025-08-27	1,151,779	0	1,982,001	58.1%
2025-08-26	535,461	0	1,681,657	31.8%
2025-08-25	417,407	6,000	1,300,944	32.1%
2025-08-22	800,594	2,900	3,459,518	23.1%
2025-08-21	538,269	59,442	1,739,316	30.9%
2025-08-20	653,253	8,471	1,851,398	35.3%
2025-08-19	873,321	4,985	2,356,972	37.1%
2025-08-18	996,713	2,895	2,546,372	39.1%
2025-08-15	802,278	13,079	2,126,523	37.7%
2025-08-14	1,734,423	0	3,572,750	48.5%
2025-08-13	1,518,808	22,282	5,926,618	25.6%
2025-08-12	802,698	0	2,108,050	38.1%
2025-08-11	970,405	312	2,231,363	43.5%
2025-08-08	1,110,487	0	2,220,895	50.0%
2025-08-07	929,271	0	2,197,502	42.3%
2025-08-06	1,452,297	300	2,147,098	67.6%
2025-08-05	513,639	650	1,061,340	48.4%
2025-08-04	837,751	5,613	1,408,971	59.5%
2025-08-01	1,019,365	901	1,797,066	56.7%
2025-07-31	421,230	648	1,014,393	41.5%
2025-07-30	769,000	1,889	1,675,709	45.9%
2025-07-29	1,102,475	54,262	2,091,312	52.7%
2025-07-28	1,612,057	1,152	3,202,412	50.3%
2025-07-25	890,172	16,332	1,787,553	49.8%
2025-07-24	835,097	18,753	1,924,198	43.4%
2025-07-23	1,170,850	186	3,476,031	33.7%
2025-07-22	837,704	792	1,734,473	48.3%
2025-07-21	937,222	661	2,021,117	46.4%
2025-07-18	1,086,701	17,670	1,997,790	54.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE